Sagility Q1 FY27 Earnings Call — Analysis (NSE: SAGILITY)
Sagility delivered a strong Q1 FY27 with 27.6% YoY revenue growth and 24% adjusted EBITDA margin, absorbing a significant minimum wage hike, and reiterated FY27 low double-digit organic constant currency growth guidance and 24-25% margin.
The take
Q1FY27 Revenue (reported) ₹1,963.5 Cr ( +27.6% YoY ) . New guidance — FY27 organic constant currency reven… low double-digit . New story: Managed services and AI-led transformation .
Results
Revenue ₹1,963.5 Cr +27.6% YoY (15.2% CC organic 14.9%); adjusted EBITDA ₹471.6 Cr +27.9% YoY, margin 24%; adjusted PAT ₹269.7 Cr +35.1% YoY.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue (reported) | ₹1,963.5 Cr | +27.6% | yoy · Q1FY27 |
| Adjusted EBITDA | ₹471.6 Cr | +27.9% | yoy · Q1FY27 |
| Adjusted PAT | ₹269.7 Cr | +35.1% | yoy · Q1FY27 |
| Adjusted EBITDA margin | 24% | -90 bps | qoq · Q1FY27 · vs Q4FY26 margin 24.9% |
| Operating cash flow | ₹316.1 Cr | point_in_time · Q1FY27 | |
| Net debt | ₹111 Cr | point_in_time · end Q1FY27 | |
| New wins (steady state ACV) | ₹333.6 Cr | point_in_time · Q1FY27 · $35.3 million ACV |
Guidance
FY27 organic constant currency revenue growth low double-digit; FY27 adjusted EBITDA margin 24-25% despite 120 bps impact from minimum wage increase.
What management committed to
- [Sagility] reiterates FY 2027 organic constant currency revenue growth of low double-digit. — low double-digit, FY27
- [Sagility] maintains FY 2027 adjusted EBITDA margin guidance of 24% to 25% despite absorbing 120 bps incremental impact from minimum wage increases in Karnataka and Telangana. — 24% to 25%, FY27
- If the eventual outcome on minimum wages results in a lower impact than the [estimated] 120 bps, [Sagility] could be at the upper end of [the 24-25% margin range] or even higher. — upper end of that range or even higher, FY27
- [Sagility] expects the proportion of seasonal revenue to total revenue in FY 2027 to be similar to the ~6% proportion in FY 2026. — similar (~6%), FY27
- [Sagility] remains on track to fully repay its outstanding debt during FY 2027. — FY27
- [Sagility] will continue to focus a lot more of its expansion in states outside of Karnataka and Telangana to mitigate the impact of future minimum wage hikes. — ongoing (12-18 months)
Key themes
Strong execution, demand resilience, and AI-led transformation
How the narrative shifted
- Payer cost pressure driving outsourcing demand: Management positions US payer margin pressure and rising medical costs as a structural tailwind for Sagility’s domain-led, outcome-based services.
- Managed services and AI-led transformation: Sagility is shifting toward integrated, outcome-driven managed service deals with AI orchestration, aiming to differentiate and capture larger wallet share.
- Acquisition-led capability and mid-market expansion: CareSeed and BroadPath acquisitions add quality analytics platforms and mid-market payer clients, creating cross-sell opportunities and deepening healthcare domain capabilities.
- Wage cost headwind and margin resilience: A significant unexpected Karnataka/Telangana minimum wage hike is a margin headwind, but management commits to absorbing it through efficiency, favourable FX, and geographic diversification.
- Seasonal enrolment-driven volume visibility: Recurring seasonal revenue from open enrolment (~6% of total) provides a predictable Q3/Q4 uptick, though exact magnitude depends on client plans finalised by September.
- AI deflation as competitive moat: Management frames 1-2% annual revenue deflation from automation/AI not as a threat but as a value proposition to win clients seeking cost reduction, with gains from workflow redesign.
Operational commentary
- Managed service deal constructs gaining traction: Sagility is taking operational ownership and accountability for outcomes, moving beyond fragmented process-led models; Sagility Synchrony AI orchestration platform connecting workflows across claims and adjustments.
- CareSeed acquisition closed June 2026, adding HEDIS reporting/quality analytics platforms (Forecast, Harvest), 26 new mid-/small-market payer clients, and strengthening capabilities in quality and Medicare Advantage.
- BroadPath cross-sell pipeline active with 6-7 opportunities in active conversations; CareSeed cross-sell expected to target mid-market clients with abstraction services and broader care operations.
- New win momentum healthy: $35.3M steady state ACV signed across 18 existing clients and 1 new logo, reflecting broad-based expansion within existing relationships.
- Shift of large onshore volume to offshore for a top-4/5 client is temporarily reducing that cohort's revenue but expected to be margin accretive.
- Seasonal enrolment revenue expected to remain ~6% of total revenue in FY27, similar to FY26, recurring each year during Q3-Q4.
- Employee base heavily concentrated in Karnataka and Telangana (65-70% headcount), where statutory minimum wages were raised significantly; company expanding in other states and increasing operational efficiency to mitigate future impact.
- AI-led deflation remains in the 1-2% range (historically 100-150 bps, may rise); positioning this as a value proposition to win cost-conscious clients rather than a margin threat.
Analyst Q&A
Q. What is the proportion of employees outside Karnataka and Telangana, and can the 120 bps wage impact be recovered?
Ramesh Gopalan said less than 15-20% of employees are outside Karnataka and Telangana; mitigation via expansion in other states and operational efficiency will take 12-18 months. Srinivas Mattapalli added that 65-70% headcount is in Bangalore and Hyderabad.
Q. Is the only constraint to growth management's ability to scale up delivery?
Ramesh Gopalan clarified scaling execution is not a concern; rather, timing of large managed service deals (conversations lasting 3-6 months) and the mix of deal types (not all are managed services) are factors.
Q. Can you split the 15% organic CC growth into volume from FY26 new clients versus existing clients?
Ramesh Gopalan said specific split numbers not handy but will follow up; growth is broad-based with most wins coming from 15-20 existing clients each quarter.
Q. Why is the lower end of the margin guidance not raised despite no further headwinds mentioned?
Ramesh Gopalan noted that the full quarter impact of the minimum wage hike will be felt in Q2, and hedging gains affect actual EBITDA but not adjusted; they will narrow the range after Q2.
Q. How far along is the second planned clinical services acquisition mentioned at the Investor Day?
Ramesh Gopalan stated it depends on availability of capabilities in clinical, provider, or healthcare technology spaces, but no timeline given.
Research and educational content only. Not investment advice.